tbc (golimumab) (golimumab)

pCPA File Number: 23486
Negotiation Status:
Active Negotiation
Indication(s):
Rheumatoid Arthritis (RA)
- Psoriatic Arthritis (PsA)
- Ankylosing Spondylitis (AS)
- Non-radiographic Axial Spondyloarthritis (nr Ax SpA)
- Ulcerative Colitis (UC)
Sponsor/Manufacturer:
Jamp Pharma Corporation
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable